-
Posted by
Two Blokes April 22, 2025 -
Filed in
Stock
-
17 views
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360\u2122 -- powered by Guardant Health liquid biopsy genomic data -- and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision oncology. The agreement will fully leverage ConcertAI's newly launched Translational360\u2122, an integrated research-grade longitudinal clinical molecular databa.
